Abbott
NYSE ABT · Abbott Park, IL
Works in GI & liver · Infectious disease · Metabolic & endocrine · Renal & urogenital · Respiratory · Women's health
Abbott is a clinical trial sponsor based in Abbott Park, IL, listed as NYSE ABT. It has 1 active clinical trial with 250 planned participants, across 6 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.
Trial track record · since 2021
Financials · NYSE ABT
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Abbott
Abbott is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 250 planned participants, in GI & liver, Infectious disease, Metabolic & endocrine, Renal & urogenital and other areas. Since 2021 it has completed 10 trials and stopped 0 early.
Abbott is based in Abbott Park, IL and is listed as NYSE ABT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Abbott; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-03.
Approve Suite is not affiliated with Abbott.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.